Kazakh scientists and students have developed a new smart bionic arm prosthesis controlled by electrical impulses generated by the user’s muscles, marking an important step for rehabilitation technology and prosthetic innovation in Central Asia.
The project was reported by Qazinform News Agency after being presented at GITEX AI Central Asia & Caucasus. The technology is designed to allow users to perform different hand gestures and grip objects of various shapes, supporting greater independence in everyday activities.
According to project developer Ayaulym Assylbekova, the device is being created by an interdisciplinary team of Kazakh scientists, master’s and doctoral students, and engineering students under the supervision of a university professor. The “smart hand” works with a special bracelet fitted with electromyography, or EMG, sensors, which detect muscle activity and transmit the data to a machine-learning system.
For the orthotics and prosthetics community, the use of EMG control is significant. EMG-based prosthetic systems detect electrical activity from residual muscles and convert those signals into commands for a prosthetic hand, wrist or arm. In practical terms, when the user contracts specific muscles, the system recognises the signal pattern and triggers the prosthesis to perform a movement, such as opening, closing or gripping.
The Kazakh team’s system uses machine-learning algorithms to analyse signal sequences, recognise specific gestures and send commands to the prosthesis. The aim is to give users more natural control over hand function and improve their ability to complete daily tasks that may otherwise be difficult after upper-limb loss.
For IMEA CPO readers, this development is relevant because it reflects a wider shift in prosthetics: advanced bionic systems are no longer being developed only in North America, Western Europe or Japan. Emerging innovation ecosystems in Central Asia, the Middle East, Africa and South Asia are increasingly working on local solutions for assistive technology, robotics, digital health and rehabilitation.
The project has reportedly been under development for two years and is supported by a research grant. The team has worked not only on software and control systems, but also on materials. Assylbekova said the developers studied material selection carefully, including the combination of titanium and plastic, to support comfort and reduce risks of allergic reaction or skin irritation.
This attention to user comfort is important. Upper-limb prosthetic adoption is often affected by weight, socket comfort, control reliability, heat, skin tolerance, battery performance, repairability and whether the device is useful in the user’s real daily environment. A technically advanced prosthesis can still be abandoned if it is uncomfortable, unreliable, too heavy or difficult to maintain.
The Kazakh team is now working on the third prototype of the device, with engineers continuing to refine the hand design to improve movement accuracy and functionality. Full-scale testing has not yet been completed, meaning the system remains in development rather than ready for widespread clinical deployment.
That distinction matters. For promising bionic technologies to move from prototype to patient care, they must pass through several stages: user testing, mechanical validation, safety review, durability assessment, clinical trials, regulatory approval, fitting protocols, training systems, maintenance planning and long-term outcome monitoring.
For clinicians, the most important question will be whether the device can deliver reliable function for real users with upper-limb loss. EMG control can be powerful, but it can also be affected by electrode placement, sweat, residual limb shape, muscle fatigue, signal noise and user training. A successful device must therefore combine good engineering with careful clinical fitting and rehabilitation support.
The project also highlights the importance of interdisciplinary development. Bionic prosthetics require collaboration between engineers, materials scientists, clinicians, prosthetists, rehabilitation therapists, software developers, user-experience specialists and people with limb loss. Without patient-centred testing, a device may perform well in demonstrations but fail to meet practical needs.
The team’s future ambitions are also notable. According to Qazinform, the researchers intend to expand their work into an exoskeleton and a bionic leg prosthesis, suggesting a broader plan to develop rehabilitation and prosthetic technologies in Kazakhstan.
For Central Asia, this could be strategically important. Countries across the region face rehabilitation needs linked to trauma, diabetes, vascular disease, congenital limb difference, workplace injury, road traffic accidents and ageing populations. Local development of prosthetic and rehabilitation technologies could help reduce dependence on imported high-cost systems, especially if combined with training, local service capacity and appropriate regulatory pathways.
For the wider IMEA region, the Kazakh bionic arm project raises several important themes:
The project also connects with wider global research in robotic upper-limb prostheses. A 2025 review in Sensors notes that EMG signals are widely used in human-machine interfaces because they translate residual muscle activity into prosthetic commands, helping people with limb loss regain function and independence.
For users, the value of such technology is measured not by technical novelty, but by what it makes possible: holding objects, preparing food, using tools, dressing, studying, working and participating more fully in daily life. That is why clinical translation will be crucial for the Kazakh project.
If the team can successfully move from prototype to tested clinical solution, the smart bionic arm could become an important example of Central Asian innovation in assistive technology. It may also encourage universities, governments and investors across the region to support rehabilitation engineering as a priority area.
For IMEA CPO, the message is clear: the future of prosthetics will be shaped not only by established global manufacturers, but also by emerging research teams working on locally relevant, digitally enabled and increasingly intelligent devices. Kazakhstan’s EMG-controlled bionic arm is still in development, but it points toward a more distributed future for prosthetic innovation.